10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||||||||||||||
| ||||||||||||||
|
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | |||
JOHNSON & JOHNSON | |||
Ticker: JNJ Fiscal Year: 2020 | |||
Consolidated Statements of Earnings | |||
Period Ending Jan 3, 2021 10-K (Filed: Feb 22, 2021) | |||
(In Millions, except shares in Thousands) | |||
12 Months Ended | 12 Months Ended | 12 Months Ended | |
Jan 3, 2021 | Dec 29, 2019 | Dec 30, 2018 | |
Sales to customers | $ 82,584 | 82,059 | 81,581 |
Cost of products sold | 28,427 | 27,556 | 27,091 |
Gross profit | 54,157 | 54,503 | 54,490 |
Selling, marketing and administrative expenses | 22,084 | 22,178 | 22,540 |
Research and development expense | 12,159 | 11,355 | 10,775 |
In-process research and development (Note 5) | 181 | 890 | 1,126 |
Interest income | (111) | (357) | (611) |
Interest expense, net of portion capitalized (Note 4) | 201 | 318 | 1,005 |
Other (income) expense, net | 2,899 | 2,525 | 1,405 |
Restructuring (Note 20) | 247 | 266 | 251 |
Earnings before provision for taxes on income | 16,497 | 17,328 | 17,999 |
Provision for taxes on income (Note 8) | 1,783 | 2,209 | 2,702 |
Net earnings | 14,714 | 15,119 | 15,297 |
Net earnings per share (Notes 1 and 15) | |||
Basic (in dollars per share) | 5.59 | 5.72 | 5.70 |
Diluted (in dollars per share) | 5.51 | 5.63 | 5.61 |
Average shares outstanding (Notes 1 and 15) | |||
Basic (in shares) | 2,632,800 | 2,645,100 | 2,681,500 |
Diluted (in shares) | 2,670,700 | 2,684,300 | 2,728,700 |
External Links | |
JOHNSON & JOHNSON (JNJ) Fiscal Year 2020 | |
Statements of 10-K in Excel | https://www.sec.gov/.../Financial.xlxs |
Complete 10-K in HTML | https://www.sec.gov/.../10-K.html |
Complete 10-K in XBRL | https://www.sec.gov/.../10-K-xbrl.zip |